You are here
The Stork Helps Couples Tackle Mild Infertility at Home
a blog by Kim Griffiths, June 10, 2013
A new product authorized by the FDA has been launched to help couples take a proactive step toward trying to conceive before undergoing more advanced fertility treatments like in vitro fertilization (IVF).
The Stork Conception Aid, a Rinovum Women's Health product, is available by prescription only and should be used under the guidance of your OB-GYN or fertility doctor. It helps couples address their inability to conceive with traditional intercourse in the comfort and privacy of their own home. The Stork kit includes a cervical cap inside a condom-like sheath which collects semen and can then be inserted via applicator (similar to a tampon applicator) just outside the woman’s cervix. This method treats mild male factor infertility including low count or low motility, or mild female factor infertility like hostile cervical mucus by eliminating the need for many strong swimming sperm to navigate through sub-optimal vaginal conditions.
Couples are instructed to use The Stork on the three most fertile days of a woman’s cycle which can be tracked using an Ovulation Prediction Kit (OPK) or by charting Basal Body Temperature (BBT). The cost of one Stork kit containing three devices to be used in one menstrual cycle costs $240. Like an at-home intrauterine insemination (IUI), The Stork is a first line treatment for couples not yet ready to pursue IVF.